Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future?
暂无分享,去创建一个
[1] Xuan Zeng,et al. Bacteria-based bioactive materials for cancer imaging and therapy. , 2023, Advanced drug delivery reviews.
[2] I. Gentschev,et al. Tumor Colonization and Therapy by Escherichia coli Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome , 2022, Cancers.
[3] Zhiyi Chen,et al. Recent Advances in Bacteria-Based Cancer Treatment , 2022, Cancers.
[4] Jinhui Wu,et al. Recent advances in bacterial therapeutics based on sense and response , 2022, Acta pharmaceutica Sinica. B.
[5] S. Hasnain,et al. Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer. , 2022, International journal of medical microbiology : IJMM.
[6] T. Tang,et al. Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives , 2022, Frontiers in Oncology.
[7] R. Lamont,et al. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma. , 2022, Periodontology 2000.
[8] D. Barh,et al. Bugs as drugs: neglected but a promising future therapeutic strategy in cancer. , 2022, Future oncology.
[9] A. Zloza,et al. Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy , 2021, Vaccines.
[10] F. Rommasi. Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are , 2021, Oncology and Therapy.
[11] Li-wen Ren,et al. Tumorigenic bacteria in colorectal cancer: mechanisms and treatments , 2021, Cancer biology & medicine.
[12] J. Dahlstrom,et al. Simple and effective bacterial-based intratumoral cancer immunotherapy , 2021, Journal for ImmunoTherapy of Cancer.
[13] M. Druszczyńska,et al. Dual Nature of Relationship between Mycobacteria and Cancer , 2021, International journal of molecular sciences.
[14] Qian Wang,et al. Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5‐aminolevulinic acid , 2021, Microbial biotechnology.
[15] A. Khan,et al. Salmonella enterica subsp. enterica host-pathogen interactions and their implications in gallbladder cancer. , 2021, Microbial pathogenesis.
[16] Shaobing Zhou,et al. Bacteria‐Based Cancer Immunotherapy , 2021, Advanced science.
[17] S. Das,et al. Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors , 2020, Oncology letters.
[18] In Young Hwang,et al. Tweak to Treat: Reprograming Bacteria for Cancer Treatment. , 2020, Trends in cancer.
[19] J. Sfakianos,et al. Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. , 2020, Urologic oncology.
[20] M. Medina‐Sánchez,et al. Engineering microrobots for targeted cancer therapies from a medical perspective , 2020, Nature Communications.
[21] Qing Liu,et al. New technologies in developing recombinant‐attenuated bacteria for cancer therapy , 2020, Biotechnology and bioengineering.
[22] Michael Sigal,et al. Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis , 2020, International journal of molecular sciences.
[23] Shruti S Sawant,et al. Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment , 2020, International journal of molecular sciences.
[24] M. Alipour. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer , 2020, Journal of Gastrointestinal Cancer.
[25] Suad A Al-Hilu,et al. Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition , 2020, International journal of microbiology.
[26] S. Mandal,et al. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. , 2020, Biochimie.
[27] S. Makuch,et al. Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications. , 2020, Life sciences.
[28] Qing Liu,et al. Bacteria-derived minicells for cancer therapy. , 2020, Cancer letters.
[29] Jinyao Liu,et al. Bacteria and bacterial derivatives as drug carriers for cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[30] Muzaheed. Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors , 2020, TheScientificWorldJournal.
[31] C. Harris,et al. Cancer-type-Specific Bacteria: Freeloaders or Partners? , 2020, Cancer cell.
[32] M. Vadala',et al. The long‐standing history of Corynebacterium parvum, immunity, and viruses , 2020, Journal of medical virology.
[33] C. Atreya,et al. Probing the tumor micro(b)environment , 2020, Science.
[34] Noam Shental,et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.
[35] Davy Sinnaeve,et al. Identification of the Molecular Determinants Involved in Antimicrobial Activity of Pseudodesmin A, a Cyclic Lipopeptide From the Viscosin Group , 2020, Frontiers in Microbiology.
[36] A. Barzegari,et al. Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours , 2020, Journal of drug targeting.
[37] A. Avan,et al. Bacteria and cancer: Different sides of the same coin. , 2020, Life sciences.
[38] F. Guyot,et al. Engineering E. coli for magnetic control and the spatial localization of functions , 2020, bioRxiv.
[39] N. Shental,et al. Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria , 2020, Oncoimmunology.
[40] J. Ferlay,et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. , 2019, The Lancet. Global health.
[41] J. Min,et al. Bacteria-cancer interactions: bacteria-based cancer therapy , 2019, Experimental & Molecular Medicine.
[42] N. Kunda. Antimicrobial peptides as novel therapeutics for nonsmall cell lung cancer. , 2019, Drug discovery today.
[43] S. Staibano,et al. Prevalence of Chlamydia psittaci, Chlamydia pneumoniae, and Chlamydia trachomatis Determined by Molecular Testing in Ocular Adnexa Lymphoma Specimens. , 2019, American journal of clinical pathology.
[44] J. Sauer,et al. Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity , 2019, Current Clinical Microbiology Reports.
[45] A. Ghasemian,et al. Bacterial l‐asparaginases for cancer therapy: Current knowledge and future perspectives , 2019, Journal of cellular physiology.
[46] F. Shafiee,et al. Targeted Diphtheria Toxin-Based Therapy: A Review Article , 2019, Front. Microbiol..
[47] Tingtao Chen,et al. Oncolytic Bacteria and their potential role in bacterium-mediated tumour therapy: a conceptual analysis , 2019, Journal of Cancer.
[48] Miryoung Song,et al. Development of bacteria as diagnostics and therapeutics by genetic engineering , 2019, Journal of Microbiology.
[49] Silvia Mercado-Sáenz,et al. Intestinal microbiota and colorectal cancer , 2019 .
[50] Shibin Zhou,et al. Tumour-targeting bacteria engineered to fight cancer , 2018, Nature Reviews Cancer.
[51] C. Jobin,et al. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin , 2018, Gut.
[52] B. Negahdari,et al. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview , 2018, Journal of cellular physiology.
[53] Shibin Zhou,et al. White paper on microbial anti-cancer therapy and prevention , 2018, Journal of Immunotherapy for Cancer.
[54] M. Ingersoll,et al. Mechanisms of BCG immunotherapy and its outlook for bladder cancer , 2018, Nature Reviews Urology.
[55] T. Karpiński,et al. Anticancer Activity of Bacterial Proteins and Peptides , 2018, Pharmaceutics.
[56] A. Lavie,et al. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo. , 2018, Cancer research.
[57] Hong-li Liu,et al. Fusobacterium nucleatum and colorectal cancer: A review , 2018, World journal of gastrointestinal oncology.
[58] Shiyu Song,et al. The role of bacteria in cancer therapy – enemies in the past, but allies at present , 2018, Infectious Agents and Cancer.
[59] M. Fol,et al. Microorganisms in the Treatment of Cancer: Advantages and Limitations , 2018, Journal of immunology research.
[60] Pamela A. Silver,et al. Engineering bacteria for diagnostic and therapeutic applications , 2018, Nature Reviews Microbiology.
[61] S. Mousavi,et al. The potential roles of bacteria to improve radiation treatment outcome , 2018, Clinical and Translational Oncology.
[62] M. Velasco,et al. Bacteria in cancer therapy: beyond immunostimulation , 2018 .
[63] R. Hoffman,et al. Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions , 2018, Front. Microbiol..
[64] Tal Danino,et al. Advances in bacterial cancer therapies using synthetic biology. , 2017, Current opinion in systems biology.
[65] E. D. Di Domenico,et al. Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer , 2017, International journal of molecular sciences.
[66] S. Weiss,et al. Tumour‐targeting bacteria‐based cancer therapies for increased specificity and improved outcome , 2017, Microbial biotechnology.
[67] M. Redinbo,et al. The role of the microbiome in cancer development and therapy , 2017, CA: a cancer journal for clinicians.
[68] M. Büchler,et al. A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer , 2017, Oncoimmunology.
[69] A. Ferreri,et al. Bacteria associated with marginal zone lymphomas. , 2017, Best practice & research. Clinical haematology.
[70] Elena Cerrada,et al. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer , 2017, International journal of molecular sciences.
[71] M. Sitti,et al. Bioengineered and biohybrid bacteria-based systems for drug delivery. , 2016, Advanced drug delivery reviews.
[72] S. Martel,et al. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions , 2016, Nature nanotechnology.
[73] Jin Hai Zheng,et al. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy , 2016, Theranostics.
[74] L. Piao,et al. Radiotherapy combined with an engineered Salmonella typhimurium inhibits tumor growth in a mouse model of colon cancer , 2016, Experimental animals.
[75] S. Weiss,et al. Bacteria in Cancer Therapy: Renaissance of an Old Concept , 2016, International journal of microbiology.
[76] P. Kučerová,et al. Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment , 2016, Anti-cancer drugs.
[77] Shibin Zhou,et al. Clostridium novyi-NT in cancer therapy , 2016, Genes & diseases.
[78] B. V. Rubtsov. Bacteriological examination of malignant tumors (retrospective overview) , 2015 .
[79] Ivan Rusyn,et al. Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.
[80] S. Kaur,et al. Bacteriocins as Potential Anticancer Agents , 2015, Front. Pharmacol..
[81] M. Michalska,et al. Pseudomonas Exotoxin A: optimized by evolution for effective killing , 2015, Front. Microbiol..
[82] K. Kinzler,et al. Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats , 2015, Oncotarget.
[83] B. Kreikemeyer,et al. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo , 2015, Cancer biology & therapy.
[84] A. Kerr. The oral microbiome and cancer. , 2015, Journal of dental hygiene : JDH.
[85] Robert S. Benjamin,et al. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses , 2014, Science Translational Medicine.
[86] Jiansheng Wang,et al. Tumor-colonizing bacteria: A potential tumor targeting therapy , 2014, Critical reviews in microbiology.
[87] L. Rodrigues,et al. Effects of biosurfactants on the viability and proliferation of human breast cancer cells , 2014, AMB Express.
[88] R. Medeiros,et al. Chlamydia trachomatis infection: implications for HPV status and cervical cancer , 2014, Archives of Gynecology and Obstetrics.
[89] Yeonkyung Lee,et al. New paradigm for tumor theranostic methodology using bacteria-based microrobot , 2013, Scientific Reports.
[90] Eduardo J. Gudiña,et al. Potential therapeutic applications of biosurfactants. , 2013, Trends in pharmacological sciences.
[91] Jin Hai Zheng,et al. Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[92] M. Rescigno,et al. Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. , 2013, Blood.
[93] M. Tangney,et al. Bacteria and tumours: causative agents or opportunistic inhabitants? , 2013, Infectious Agents and Cancer.
[94] T. Williams,et al. Magnetococcus marinus gen. nov., sp. nov., a marine, magnetotactic bacterium that represents a novel lineage (Magnetococcaceae fam. nov., Magnetococcales ord. nov.) at the base of the Alphaproteobacteria. , 2013, International journal of systematic and evolutionary microbiology.
[95] E. Lara-Padilla,et al. Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line. , 2013, Asian Pacific Journal of Cancer Prevention.
[96] S. Galdy,et al. Streptococcus bovis endocarditis and colon cancer: myth or reality? A case report and literature review , 2012, BMJ Case Reports.
[97] I. Banat,et al. Microbial biosurfactants: challenges and opportunities for future exploitation. , 2012, Trends in biotechnology.
[98] W. Duan,et al. Clostridial Spores for Cancer Therapy: Targeting Solid Tumour Microenvironment , 2012, Journal of toxicology.
[99] V. Nardicchi,et al. Botulinum Toxin Type-A Toxinactivity in Prostate Cancer Cell Lines , 2012, Urologia.
[100] Y. Chae,et al. Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-α in mice , 2011, Applied Microbiology and Biotechnology.
[101] N. Forbes. Engineering the perfect (bacterial) cancer therapy , 2010, Nature Reviews Cancer.
[102] J. Parsonnet,et al. Role of Bacteria in Oncogenesis , 2010, Clinical Microbiology Reviews.
[103] D. Waisman,et al. Sensitivity of Cancer Cells to Truncated Diphtheria Toxin , 2010, PloS one.
[104] A. Prakash,et al. Bacteria in cancer therapy: a novel experimental strategy , 2010, Journal of Biomedical Science.
[105] Hyung-Seok Kim,et al. Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[106] Michelle Cronin,et al. A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. , 2010, Human gene therapy.
[107] N. Forbes,et al. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice , 2009, British Journal of Cancer.
[108] M. Albert,et al. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer. , 2009, The Journal of urology.
[109] J. E. Pemberton,et al. Efficient purification of the biosurfactant viscosin from Pseudomonas libanensis strain M9-3 and its physicochemical and biological properties. , 2008, Journal of natural products.
[110] K. Rice,et al. Molecular Control of Bacterial Death and Lysis , 2008, Microbiology and Molecular Biology Reviews.
[111] S. Akira,et al. Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest , 2005, FEBS letters.
[112] B. Peters,et al. Pharmacologic and toxicologic evaluation of C. novyi-NT spores. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[113] R. Schreiber,et al. The three Es of cancer immunoediting. , 2004, Annual review of immunology.
[114] A. Chakrabarty,et al. Microorganisms and Cancer: Quest for a Therapy , 2003, Journal of bacteriology.
[115] M. Wainwright,et al. Is this the historical 'cancer germ'? , 2003, Medical hypotheses.
[116] J. Bickels,et al. Coley's toxin: historical perspective. , 2002, The Israel Medical Association journal : IMAJ.
[117] M. Löhr,et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. , 2001, Gastroenterology.
[118] A. M. Livingston,et al. Some cultural, immunological, and biochemical properties of Progenitor cryptocides. , 1974, Transactions of the New York Academy of Sciences.
[119] A. M. Livingston,et al. Demonstration of progenitor cryptocides in the blood of patients with collagen and neoplastic diseases. , 1972, Transactions of the New York Academy of Sciences.
[120] W. F. Robertson. THE RELATION OF CARCINOMA TO INFECTION * , 1921, British medical journal.
[121] S. Aifa,et al. Antibacterial, anti-adherent and cytotoxic activities of surfactin(s) from a lipolytic strain Bacillus safensis F4 , 2019, Biodegradation.
[122] SOME AROMATIC AMINES AND RELATED COMPOUNDS VOLUME 127 IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS , 2019 .
[123] K. Nybo. PART I: FIGHTING CANCER WITH DEADLY BACTERIA. , 2018, BioTechniques.
[124] D. Kalvakolanu,et al. Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges , 2017, Cytokine.
[125] W. Zam. Arginine enzymatic deprivation and diet restriction for cancer treatment , 2017 .
[126] J. Burke. Cancer and Infection , 2008 .
[127] Ľ.,et al. THE MICROCOCCUS NEOFOBMANS. ITS CULTURAL CHARACTERS AND PATHOGENIC1TY AND THE RESULTS OF THE ESTIMATION OF THE OPSONIC AND AGGLUTINATIVE PROPERTIES OF THE SERUM OF PATIENTS SUFFERING FROM MALIGNANT DISEASE ON THIS ORGANISM AND ON THE STAPHYLOCOCCUS ALBUS. , 2007 .
[128] C. Lewis,et al. Use of bacteria in anti-cancer therapies. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[129] C. Starnes,et al. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. , 1994, Pharmacology & therapeutics.
[130] H. Stam,et al. The spontaneous regression of cancer. A review of cases from 1900 to 1987. , 1990, Acta oncologica.
[131] H. C. Nauts,et al. Coley toxins--the first century. , 1990, Advances in experimental medicine and biology.